Target intelligence / Profile preview

Ferric iron (Fe3+)

Target
Fe3+
Molecular classification
Metal ion, Inorganic molecule
01

Overview

Ferric iron (Fe3+) is the trivalent oxidation state of iron and serves as an essential micronutrient required for fundamental biological processes, including DNA synthesis, electron transport in the mitochondria, and oxygen metabolism (NIH Office of Dietary Supplements). In extracellular environments such as blood plasma, ferric iron is strictly sequestered by transport proteins like transferrin to prevent the formation of toxic reactive oxygen species through the Fenton reaction and to limit its availability to invading pathogens (StatPearls: Iron Toxicity). In mucosal environments, particularly the gastrointestinal tract, ferric iron levels are a critical determinant of the gut microbiome composition, as many enteric pathogens rely on specialized scavenging molecules called siderophores to acquire iron for virulence (PubMed: PMID 26015570). Therapeutic interventions targeting ferric iron include the use of systemic chelators like deferoxamine to treat iron overload and oral binders like sucroferric oxyhydroxide to manage hyperphosphatemia in chronic kidney disease (FDA: Desferal Label; DrugBank: DB09073). Additionally, ferric iron formulations are frequently administered as supplements to correct iron deficiency anemia, though they must be carefully managed to avoid mucosal irritation and systemic toxicity (StatPearls: Iron Deficiency Anemia).

Other names
Iron (III)Trivalent ironNon-heme ironFe(III)Ferric ion
02

Mechanism of action

Chelation of ferric ions to form stable, water-soluble complexes for renal or biliary excretion; binding of dietary phosphate in the gastrointestinal tract to form insoluble ferric phosphate; supplementation to restore systemic iron stores in deficient states.

03

Biological functions

Enzyme cofactorOxygen transport and storageCellular respiration and electron transportDNA synthesisNutritional immunity
04

Disease associations

Iron overload (Hemochromatosis)Iron deficiency anemiaHyperphosphatemiaBacterial infectionNeurodegenerative disease
05

Safety considerations

Oxidative stress and tissue damage via the Fenton reactionGastrointestinal irritation and constipationSystemic toxicity (siderosis)Promotion of growth in siderophilic bacteria (e.g., Yersinia, Vibrio)Interference with the absorption of other minerals and medications
06

Interacting drugs

Deferoxamine

5 more in the full profile.

07

Biomarkers

Serum ferritinTransferrin saturation (TSAT)Serum ironTotal iron-binding capacity (TIBC)Hepcidin

Beyond the preview

Go deeper on Ferric iron (Fe3+).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Ferric iron (Fe3+).

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call